COMPANY
SCIENTIFIC APPROACH
PIPELINE
PATIENTS
CAREERS
NEWS & PUBLICATIONS
- Press Releases
- Publications
CONTACT

Pipeline cyteir 2020-09-29T13:01:44+00:00

Pipeline

Novel, Best-in-Class Drugs Targeting Key Cancer Vulnerabilities

(Click to enlarge graphic)

CYT-0851 trial

Clinical trials underway now

CONTACT INFORMATION

128 Spring St, Building A Suite 510, Lexington, MA 02421
857.285.4140

Company
Scientific Approach
Pipeline
Patients
Careers
News and Publications
Contact
Terms of Use

© Copyright Cyteir. All Rights Reserved. “Cyteir” and the Cyteir Logo are trademarks of Cyteir Therapeutics, Inc.